on More Impact AG (isin : DE000A1PG979)
US Patent Notice for More Impact AG's Innovation
More Impact AG, headquartered in Frankfurt, recently announced a significant development. Their subsidiary, BG Braingate Technology, received a Notice of Allowance from the US Patent and Trademark Office (USPTO). This notice pertains to a cutting-edge device and method for the extraction of biological components, focusing particularly on cannabinoids like CBD.
This patent recognition advances their international commercial prospects. It signifies a crucial step for marketing products developed using their patented extraction technology. These products can be administered through medical inhalers or needleless syringes based on medical needs.
Dr. Karsten Behlke, BG Braingate's Managing Director, emphasized the patent's strategic importance for international protection and commercial ventures in plant-based substances. More Impact AG's CEO, Dr. Gerald Schüssel, highlighted the patent's role in demonstrating their portfolio's technological innovations on a global stage.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all More Impact AG news